News about Gilead Sciences
One price watchdog group says no.
The FDA approved Gilead's novel cancer-fighting gene therapy.
The price of the drug, which is to be administered just once to each patient, will be $373,000.
They're more popular than ever, even though the political winds are against them.
FDA approves Novartis treatment that reengineers human cells to kill cancer